<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>LACRISERT- hydroxypropyl cellulose (type h) pellet </strong><br>Bausch &amp; Lomb Incorporated<br></p></div>
<h1><span class="Bold">LACRISERT<span class="Sup">® </span>(hydroxypropyl cellulose ophthalmic insert)</span></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_36382c84-7f68-0a75-ac67-edfde7441f01"></a><a name="section-1"></a><p></p>
<p class="First">STERILE OPHTHALMIC INSERT</p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="ID_a1fed401-b58e-e079-a471-18cf796ed5d1"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">LACRISERT<span class="Sup">®</span> (hydroxypropyl cellulose ophthalmic insert) is a sterile, translucent, rod-shaped, water soluble, ophthalmic insert made of hydroxypropyl cellulose, for administration into the inferior cul-de-sac of the eye.</p>
<p>The chemical name for hydroxypropyl cellulose is cellulose, 2-hydroxypropyl ether. It is an ether of cellulose in which hydroxypropyl groups (-CH<span class="Sub">2</span>CHOHCH<span class="Sub">3</span>) are attached to the hydroxyls present in the anhydroglucose rings of cellulose by ether linkages. A representative structure of the monomer is:</p>
<div class="Figure">
<a name="id220"></a><img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=cc7a6a52-0b77-4df7-8403-dd21c1334f6c&amp;name=lacrisert-01.jpg">
</div>
<p>The molecular weight is typically 1 × 10<span class="Sup">6</span>.</p>
<p>Hydroxypropyl cellulose is an off-white, odorless, tasteless powder. It is soluble in water below 38°C, and in many polar organic solvents such as ethanol, propylene glycol, dioxane, methanol, isopropyl alcohol (95%), dimethyl sulfoxide, and dimethyl formamide.</p>
<p>Each LACRISERT is 5 mg of hydroxypropyl cellulose. LACRISERT contains no preservatives or other ingredients. It is about 1.27 mm in diameter by about 3.5 mm long.</p>
<p>LACRISERT is supplied in packages of 60 units, together with illustrated instructions and a special applicator for removing LACRISERT from the unit dose <span class="product-label-link" type="condition" conceptid="443720" conceptname="Blister">blister</span> and inserting it into the eye. A spare applicator is included in each package.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="ID_3d6da05f-d052-9908-9bae-8ac3f781bed9"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<div class="Section" data-sectionCode="43681-6">
<a name="ID_2e173927-59d5-95c1-1985-dec2c9e8d987"></a><a name="section-3.1"></a><p></p>
<h2>Pharmacodynamics</h2>
<p class="First">LACRISERT acts to stabilize and thicken the precorneal tear film and prolong the tear film breakup time which is usually accelerated in patients with <span class="product-label-link" type="condition" conceptid="373204" conceptname="Conjunctival xerosis">dry eye</span> states. LACRISERT also acts to lubricate and protect the eye.</p>
<p>LACRISERT usually reduces the signs and symptoms resulting from moderate to severe <span class="product-label-link" type="condition" conceptid="373204" conceptname="Conjunctival xerosis">dry eye syndromes</span>, such as <span class="product-label-link" type="condition" conceptid="377283" conceptname="Conjunctival hyperemia">conjunctival hyperemia</span>, corneal and conjunctival staining with rose bengal, exudation, <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>, burning, foreign body sensation, smarting, <span class="product-label-link" type="condition" conceptid="4260194" conceptname="Photophobia">photophobia</span>, dryness and blurred or <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">cloudy vision</span>. Progressive visual deterioration which occurs in some patients may be retarded, halted, or sometimes reversed.</p>
<p>In a multicenter crossover study the 5 mg LACRISERT administered once a day during the waking hours was compared to artificial tears used four or more times daily. There was a prolongation of tear film breakup time and a decrease in foreign body sensation associated with <span class="product-label-link" type="condition" conceptid="373204" conceptname="Conjunctival xerosis">dry eye syndrome</span> in patients during treatment with inserts as compared to artificial tears; these findings were statistically significantly different between the treatment groups. Improvement, as measured by amelioration of symptoms, by slit lamp examination and by rose bengal staining of the cornea and conjunctiva, was greater in most patients with moderate to severe symptoms during treatment with LACRISERT. Patient comfort was usually better with LACRISERT than with artificial tears solution, and most patients preferred LACRISERT.</p>
<p>In most patients treated with LACRISERT for over one year, improvement was observed as evidenced by amelioration of symptoms generally associated with <span class="product-label-link" type="condition" conceptid="373204" conceptname="Conjunctival xerosis">keratoconjunctivitis sicca</span> such as burning, tearing, foreign body sensation, <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>, <span class="product-label-link" type="condition" conceptid="4260194" conceptname="Photophobia">photophobia</span> and blurred or <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">cloudy vision</span>.</p>
<p>During studies in healthy volunteers, a thickened precorneal tear film was usually observed through the slit-lamp while LACRISERT was present in the conjunctival sac.</p>
</div>
<div class="Section" data-sectionCode="43682-4">
<a name="ID_285a6d5a-c90b-e216-b798-43b19ddd11cc"></a><a name="section-3.2"></a><p></p>
<h2>Pharmacokinetics and Metabolism </h2>
<p class="First">Hydroxypropyl cellulose is a physiologically inert substance. In a study of rats fed hydroxypropyl cellulose or unmodified cellulose at levels up to 5% of their diet, it was found that the two were biologically equivalent in that neither was metabolized.</p>
<p>Studies conducted in rats fed <span class="Sup">14</span>C-labeled hydroxypropyl cellulose demonstrated that when orally administered, hydroxypropyl cellulose is not absorbed from the gastrointestinal tract and is quantitatively excreted in the feces.</p>
<p>Dissolution studies in rabbits showed that hydroxypropyl cellulose inserts became softer within 1 hour after they were placed in the conjunctival sac. Most of the inserts dissolved completely in 14 to 18 hours; with a single exception, all had disappeared by 24 hours after insertion. Similar dissolution of the inserts was observed during prolonged administration (up to 54 weeks).</p>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="ID_3a1eeafc-3fc5-6502-6e5b-96e9c33d8872"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">LACRISERT is indicated in patients with moderate to severe <span class="product-label-link" type="condition" conceptid="373204" conceptname="Conjunctival xerosis">dry eye syndromes</span>, including <span class="product-label-link" type="condition" conceptid="373204" conceptname="Conjunctival xerosis">keratoconjunctivitis sicca</span>. LACRISERT is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions.</p>
<p>LACRISERT is also indicated for patients with:<br>Exposure <span class="product-label-link" type="condition" conceptid="374035" conceptname="Keratitis">keratitis</span><br>Decreased corneal sensitivity<br>Recurrent <span class="product-label-link" type="condition" conceptid="4179918" conceptname="Corneal erosion">corneal erosions</span></p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="ID_123b752e-3e01-d7ea-4fc7-5bd766c2b6b4"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">LACRISERT is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="ID_5943ebc8-af1d-dece-fd7e-09ef347f5f28"></a><a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">Instructions for inserting and removing LACRISERT should be carefully followed.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="Precautions"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="ID_1ba34c87-4d5c-45b7-3f56-c1c7c9d0484e"></a><a name="section-7.1"></a><p></p>
<h2>General</h2>
<p class="First">If improperly placed, LACRISERT may result in <span class="product-label-link" type="condition" conceptid="4312493" conceptname="Corneal abrasion">corneal abrasion</span> (see <a href="#DA">DOSAGE AND ADMINISTRATION</a>). </p>
<p>Information for Patients</p>
<p>Patients should be advised to follow the instructions for using LACRISERT which accompany the package.</p>
<p>Because this product may produce transient <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurring of vision</span>, patients should be instructed to exercise caution when operating hazardous machinery or driving a motor vehicle.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="ID_d67f0711-376e-2f2f-8af3-2fe22dc16e98"></a><a name="section-7.2"></a><p></p>
<h2>Drug Interactions</h2>
<p class="First">Application of hydroxypropyl cellulose ophthalmic inserts to the eyes of unanesthetized rabbits immediately prior to or two hours before instilling pilocarpine, proparacaine HCl (0.5%), or phenylephrine (5%) did not markedly alter the magnitude and/or duration of the miotic, local corneal anesthetic, or mydriatic activity, respectively, of these agents. Under various treatment schedules, the anti-inflammatory effect of ocularly instilled dexamethasone (0.1%) in unanesthetized rabbits with primary <span class="product-label-link" type="condition" conceptid="4028363" conceptname="Uveitis">uveitis</span> was not affected by the presence of hydroxypropyl cellulose inserts.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="ID_2eb25af6-85dd-9b8d-69cc-123e1b56d2aa"></a><a name="section-7.3"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">Feeding of hydroxypropyl cellulose to rats at levels up to 5% of their diet produced no gross or histopathologic changes or other deleterious effects.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="ID_ec2393d3-b3f5-78a9-9251-bbae667345e8"></a><a name="section-7.4"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Safety and effectiveness in pediatric patients have not been established.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="ID_2be25f6d-3f7a-10c4-e798-cb0159b96978"></a><a name="section-7.5"></a><p></p>
<h2>Geriatric Use</h2>
<p class="First">No overall differences in safety or effectiveness have been observed between elderly and younger patients.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="ID_c403b247-1bdc-33af-8ce6-4e8fa333204a"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">The following adverse reactions have been reported in patients treated with LACRISERT, but were in most instances mild and transient:<br>Transient <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurring of vision</span> (See <a href="#Precautions">PRECAUTIONS</a>)<br><span class="product-label-link" type="condition" conceptid="372912" conceptname="Visual discomfort">Ocular discomfort</span> or irritation<br>Matting or stickiness of eyelashes<br><span class="product-label-link" type="condition" conceptid="4260194" conceptname="Photophobia">Photophobia</span><br><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity</span><br><span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">Edema</span> of the eyelids<br><span class="product-label-link" type="condition" conceptid="4146766" conceptname="Hyperemia">Hyperemia</span></p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="DA"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">One LACRISERT ophthalmic insert in each eye once daily is usually sufficient to relieve the symptoms associated with moderate to severe <span class="product-label-link" type="condition" conceptid="373204" conceptname="Conjunctival xerosis">dry eye syndromes</span>. Individual patients may require more flexibility in the use of LACRISERT; some patients may require twice daily use for optimal results.</p>
<p>Clinical experience with LACRISERT indicates that in some patients several weeks may be required before satisfactory improvement of symptoms is achieved.</p>
<p>LACRISERT is inserted into the inferior cul-de-sac of the eye beneath the base of the tarsus, not in apposition to the cornea, nor beneath the eyelid at the level of the tarsal plate. If not properly positioned, it will be expelled into the interpalpebral fissure, and may cause symptoms of a foreign body. Illustrated instructions are included in each package. While in the licensed practitioner's office, the patient should read the instructions, then practice insertion and removal of LACRISERT until proficiency is achieved.</p>
<p>NOTE: Occasionally LACRISERT is inadvertently expelled from the eye, especially in patients with shallow conjunctival fornices. The patient should be cautioned against rubbing the eye(s) containing LACRISERT, especially upon awakening, so as not to dislodge or expel the insert. If required, another LACRISERT ophthalmic insert may be inserted. If experience indicates that transient <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span> develops in an individual patient, the patient may want to remove LACRISERT a few hours after insertion to avoid this. Another LACRISERT ophthalmic insert maybe inserted if needed.</p>
<p>If LACRISERT causes worsening of symptoms, the patient should be instructed to inspect the conjunctival sac to make certain LACRISERT is in the proper location, deep in the inferior cul-de-sac of the eye beneath the base of the tarsus. If these symptoms persist, LACRISERT should be removed and the patient should contact the practitioner.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="ID_38ab23bd-18eb-aba3-1e0a-738ae8df177d"></a><a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">LACRISERT, a sterile, translucent, rod-shaped, water-soluble, ophthalmic insert made of hydroxypropyl cellulose, 5 mg, is supplied as follows:</p>
<p><span class="Bold">NDC</span> 24208-800-60 in packages containing 60 unit doses (each wrapped in an aluminum <span class="product-label-link" type="condition" conceptid="443720" conceptname="Blister">blister</span>), two reusable applicators, and a plastic storage container to store the applicators after use.</p>
<div class="Section" data-sectionCode="44425-7">
<a name="ID_4b31d522-8579-bf51-2e3b-19201badf1ec"></a><a name="section-10.1"></a><p></p>
<h2>Storage</h2>
<p class="First">Store below 30°C (86°F).</p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_208bbfc4-1709-42b1-83d0-74cb77515a36"></a><a name="section-11"></a><p></p>
<p class="First"><span class="Bold">Distributed by:</span><br>Bausch + Lomb, a division of</p>
<p>Valeant Pharmaceuticals North America LLC </p>
<p>Bridgewater, NJ 08807 USA </p>
<p><span class="Bold">Manufactured by:</span><br>DPT Lakewood, Inc.</p>
<p>Lakewood, NJ 08701 USA</p>
<p>LACRISERT is a registered trademark of Valeant Pharmaceuticals International, Inc. or its affiliates.</p>
<p>© Bausch &amp; Lomb Incorporated.</p>
<p>All rights reserved.</p>
<p>9421402</p>
<p>Rev. 05/15</p>
</div>
<div class="Section" data-sectionCode="59845-8">
<a name="ID_3041bcb0-cb11-4b1a-881e-9ca10458545d"></a><a name="section-12"></a><p></p>
<div class="Section" data-sectionCode="59845-8">
<a name="ID_83114fa2-5ea2-425a-ba46-0bcbabfa7a8b"></a><a name="section-12.1"></a><p></p>
<h2>INSTRUCTIONS FOR USING LACRISERT<span class="Sup">®</span> (hydroxypropyl cellulose ophthalmic insert) </h2>
<p class="First">Note:  Your licensed practitioner or a trained associate can demonstrate the proper use of LACRISERT<span class="Bold"><span class="Sup">®</span></span>. Please read and follow these instructions carefully for your subsequent use.</p>
<p>Clinical experience with LACRISERT indicates that in some patients several weeks may be required before satisfactory improvement of symptoms is achieved.</p>
<p>Two applicators (one spare) are supplied with each package.</p>
<p>Before opening the package of LACRISERT, wash your hands thoroughly with soap and water.</p>
<div class="Figure">
<a name="id455"></a><img alt="Figure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=cc7a6a52-0b77-4df7-8403-dd21c1334f6c&amp;name=lacrisert-02.jpg">
</div>
<p><span class="Bold">STEP 1:</span>  On a flat surface, open <span class="product-label-link" type="condition" conceptid="443720" conceptname="Blister">blister</span> pocket slowly and smoothly by <span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">peeling</span> back label area.  Each <span class="product-label-link" type="condition" conceptid="443720" conceptname="Blister">blister</span> pocket contains one LACRISERT ophthalmic insert.</p>
<div class="Figure">
<a name="id458"></a><img alt="Figure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=cc7a6a52-0b77-4df7-8403-dd21c1334f6c&amp;name=lacrisert-03.jpg">
</div>
<p><span class="Bold">STEP 2:</span>  Open applicator package with label side up.  Avoid touching grooved tip of the applicator.  Pick up applicator by the wide end and rinse the tip thoroughly under hot running tap water.  Gently shake off excess water.</p>
<div class="Figure">
<a name="id461"></a><img alt="Figure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=cc7a6a52-0b77-4df7-8403-dd21c1334f6c&amp;name=lacrisert-04.jpg">
</div>
<p><span class="Bold">STEP 3:</span>  Hold applicator with tip facing down and with forefinger on top to guide and apply gentle pressure.  Lightly press the grooved tip of the applicator onto the LACRISERT ophthalmic insert and it will adhere to the applicator.</p>
<p><span class="Bold">It is important to follow STEPS 4 and 5 carefully or you might experience difficulty in keeping LACRISERT (hydroxypropyl cellulose ophthalmic insert) in your eye.</span></p>
<div class="Figure">
<a name="id466"></a><img alt="Figure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=cc7a6a52-0b77-4df7-8403-dd21c1334f6c&amp;name=lacrisert-05.jpg">
</div>
<p><span class="Bold">STEP 4:</span>  Look into a mirror.  Starting with the right eye, turn your head to the right so that the colored part of the eye is close to your nose.  Use your free hand to grasp the lower lid between the thumb and index finger.  Pull the lid away from the eyeball and create a pocket between the white part of the eyeball and the lid.</p>
<div class="Figure">
<a name="id469"></a><img alt="Figure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=cc7a6a52-0b77-4df7-8403-dd21c1334f6c&amp;name=lacrisert-06.jpg">
</div>
<p><span class="Bold">STEP 5:</span>  Place the tip of the applicator containing LACRISERT into the pocket. Avoid touching the colored part of the eye.</p>
<p><span class="Bold">Remove the applicator. It is important, after removing the applicator, to look down, then release the lower eyelid.  LACRISERT (hydroxypropyl cellulose ophthalmic insert) should remain deep in the lower pocket recess of the eye and not near the edge of the lower eyelid.</span></p>
<p>Repeat procedure with left eye, turning head to the left so that the colored part of the eye is close to your nose.</p>
<p>Rinse the applicator thoroughly under hot running tap water after use.  Gently shake off visible water droplets and promptly return it to the storage container.  Note that the storage container provides space for a strip of two LACRISERT ophthalmic inserts next to the applicator storage compartment.</p>
<p><span class="Bold">IMPORTANT</span></p>
<p>If LACRISERT causes worsening of symptoms, or if new symptoms develop, it should be removed and your prescriber contacted.</p>
<p>Should the removal of the LACRISERT ophthalmic insert be necessary, follow these instructions.</p>
<dl>
<dt>•</dt>
<dd>Locate LACRISERT by pulling the lid away from the eyeball while looking for LACRISERT in a mirror.</dd>
<dt>•</dt>
<dd>Then close the eyelids.</dd>
<dt>•</dt>
<dd>When located, move LACRISERT upward with your fingers through the closed eyelids.</dd>
<dt>•</dt>
<dd>Keep the lids against the eyeball and LACRISERT should slip over the lid margin so that you can remove it with a clean facial tissue without touching the colored part of the eye.</dd>
</dl>
<p><span class="Bold">CAUTION:</span> Because this product may produce transient <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurring of vision</span>, you should exercise caution when operating hazardous machinery or driving a motor vehicle.</p>
<p><span class="Bold"><span class="Italics">Store below 30°C (86°F).</span></span></p>
<p><span class="Bold">Distributed by:</span><br>Bausch + Lomb, a division of</p>
<p>Valeant Pharmaceuticals North America LLC </p>
<p>Bridgewater, NJ 08807 USA </p>
<p><span class="Bold">Manufactured by:</span><br>DPT Lakewood, Inc., Lakewood, NJ 08701 USA</p>
<p>LACRISERT is a registered trademark of Valeant Pharmaceuticals International, Inc. or its affiliates.</p>
<p>© Bausch &amp; Lomb Incorporated. </p>
<p>All rights reserved.</p>
<p>9421302</p>
<p>Rev. 05/15</p>
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="PDP1"></a><a name="section-13"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 5 mg Carton of 60</h1>
<p class="First"><br><span class="Bold">BAUSCH + LOMB</span></p>
<p><span class="Bold">NDC </span>24208-800-60</p>
<p><span class="Bold">LACRISERT<span class="Sup">®</span></span><br><span class="Bold">(hydroxypropyl cellulose </span></p>
<p><span class="Bold">ophthalmic insert)</span></p>
<p><span class="Bold">5 mg</span></p>
<p><span class="Bold">FOR OPHTHALMIC USE ONLY</span></p>
<p><span class="Bold">Carton also contains two sterile</span></p>
<p><span class="Bold">applicators and a storage container</span></p>
<p><span class="Bold">Rx only</span></p>
<p><span class="Bold">CONTAINS NO PRESERVATIVE</span></p>
<p><span class="Bold">60 STERILE OPHTHALMIC INSERTS</span><br></p>
<div class="Figure">
<a name="id35482840"></a><img alt="5 mg" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=cc7a6a52-0b77-4df7-8403-dd21c1334f6c&amp;name=5%20mg.jpg">
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>LACRISERT 		
					</strong><br><span class="contentTableReg">hydroxypropyl cellulose pellet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:24208-800</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">OPHTHALMIC</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>HYDROXYPROPYL CELLULOSE (TYPE H)</strong> (hydroxypropyl cellulose (type H)) </td>
<td class="formItem">HYDROXYPROPYL CELLULOSE (TYPE H)</td>
<td class="formItem">5 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">white (translucent) </td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">OVAL (rod-shaped) </td>
<td class="formLabel">Size</td>
<td class="formItem">4mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:24208-800-60</td>
<td class="formItem">60  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">1  in 1 <span class="product-label-link" type="condition" conceptid="443720" conceptname="Blister">BLISTER</span> PACK; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:24208-800-10</td>
<td class="formItem">10  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem"></td>
<td class="formItem">1  in 1 <span class="product-label-link" type="condition" conceptid="443720" conceptname="Blister">BLISTER</span> PACK; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA018771</td>
<td class="formItem">06/01/1981</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Bausch &amp; Lomb Incorporated
							(196603781)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">DPT Lakewood, LLC</td>
<td class="formItem"></td>
<td class="formItem">077744035</td>
<td class="formItem">MANUFACTURE(24208-800)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 5/2015<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>cc7a6a52-0b77-4df7-8403-dd21c1334f6c</div>
<div>Set id: cc7a6a52-0b77-4df7-8403-dd21c1334f6c</div>
<div>Version: 1</div>
<div>Effective Time: 20150501</div>
</div>
</div> <div class="DistributorName">Bausch &amp; Lomb Incorporated</div></p>
</body></html>
